HK1019555A1 - Effervescent bisphosphonate formulation - Google Patents
Effervescent bisphosphonate formulation Download PDFInfo
- Publication number
- HK1019555A1 HK1019555A1 HK99104703A HK99104703A HK1019555A1 HK 1019555 A1 HK1019555 A1 HK 1019555A1 HK 99104703 A HK99104703 A HK 99104703A HK 99104703 A HK99104703 A HK 99104703A HK 1019555 A1 HK1019555 A1 HK 1019555A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alendronate
- sodium
- carbonate
- formulation
- phosphonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1788196P | 1996-05-17 | 1996-05-17 | |
| US17881P | 1996-05-17 | ||
| GB9613183 | 1996-06-24 | ||
| GBGB9613183.4A GB9613183D0 (en) | 1996-06-24 | 1996-06-24 | Effervescent alendronate formulation |
| PCT/US1997/008055 WO1997044017A1 (en) | 1996-05-17 | 1997-05-13 | Effervescent bisphosphonate formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1019555A1 true HK1019555A1 (en) | 2000-02-18 |
| HK1019555B HK1019555B (en) | 2004-04-30 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| EP0939624A1 (en) | 1999-09-08 |
| CA2254060A1 (en) | 1997-11-27 |
| JP2000511178A (ja) | 2000-08-29 |
| WO1997044017A1 (en) | 1997-11-27 |
| AU3005397A (en) | 1997-12-09 |
| EP0939624B1 (en) | 2003-12-17 |
| DE69726879T2 (de) | 2004-10-14 |
| CA2254060C (en) | 2007-05-01 |
| JP2009167200A (ja) | 2009-07-30 |
| DE69726879D1 (de) | 2004-01-29 |
| ATE256456T1 (de) | 2004-01-15 |
| AU712710B2 (en) | 1999-11-11 |
| ES2210529T3 (es) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0939624B1 (en) | Effervescent bisphosphonate formulation | |
| US5853759A (en) | Effervescent alendronate formulation | |
| ES2313735T3 (es) | Preparacion farmaceutica oral que contiene ibandronato. | |
| JP2005516928A (ja) | 骨異常のためのビスホスホネート液体製剤 | |
| PL179634B1 (pl) | Preparat farmaceutyczny alendronatu do podawania doustnego PL PL PL PL PL PL PL PL PL | |
| EP1175904B1 (en) | Alendronate for use in the treatment of osteoporosis | |
| AU723357B2 (en) | Liquid alendronate formulations | |
| EP0719148B1 (en) | Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt | |
| US20060034921A1 (en) | Effervescent bisphosphonate formulation | |
| US20040137058A1 (en) | Effervescent bisphosphonate formulation | |
| HK1019555B (en) | Effervescent bisphosphonate formulation | |
| US20070087052A1 (en) | Effervescent bisphosphonate formulation | |
| EP1378234A1 (en) | Effervescent bisphosphonate formulation | |
| EP1820497A2 (en) | Effervescent bisphosphonate formulation | |
| HK1108117A (en) | Effervescent bisphosphonate formulation | |
| AU6315499A (en) | Effervescent bisphosphonate formulation | |
| AU2007211965B2 (en) | Alendronate for use in the treatment of osteoporosis | |
| EP1491199A1 (en) | Pharmaceutical compositions of alendronate sodium trihydrate and process for the preparation thereof | |
| KR20000048829A (ko) | 액체 알렌드로네이트 제형 | |
| WO2012093976A1 (en) | A composition comprising ibandronate at least 50 % of a filling agent and a sweetener | |
| IL153109A (en) | An effective pharmaceutical composition for inhibiting bone resorption in humans containing alendronic acid or its acceptable pharmaceutical salt or mixture | |
| ME00862B (me) | Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PE | Patent expired |
Effective date: 20170512 |